House of Commons Hansard Written Answers for 13 Jun 1996 (pt 5)

Walsgrave Hospital, Coventry

Mr. Jim Cunningham: To ask the Secretary of State for Health how many patients had their operations cancelled on the day of admission at Walsgrave hospital, Coventry, in each year since 1990. [32256]

Mr. Horam: The information on individual hospitals is not available centrally. The hon. Member may wish to contact Mr. Gary Reay, chairman of the Walsgrave Hospital NHS trust for details.

Mr. Jim Cunningham: To ask the Secretary of State for Health what was the percentage of patients not assessed within five minutes at Walsgrave hospital, Coventry, for each year for which figures are available.[32255]

Mr. Horam: This information can be obtained from the performance tables publication for 1993-94 and 1994-95, copies of which are available in the Library.

13 Jun 1996 : Column: 238

Lariam

Ms Corston: To ask the Secretary of State for Health how many cases of reported and suspected adverse reactions to Lariam have been notified during the last three years for which figures are available. [32282]

Mr. Malone: The Medicines Control Agency has received 878 reports of 2,493 suspected adverse reactions associated with Lariam between 7 June 1993 and 7 June 1996. During this time, in excess of four hundred thousand patients have received Lariam. The reports received are consistent with the known safety profile of Lariam as described in the authorised product information.

Ms Corston: To ask the Secretary of State for Health what representations he has received from professional bodies and the Committee on Safety of Medicines on the anti-malarial drug Lariam. [32284]

Mr. Malone: The Department and the Medicines Control Agency have received representations from doctors and other health professionals and bodies representing health professionals and have responded to the issues raised. The Committee on Safety of Medicines, as an independent expert advisory body to the Licensing Authority, provides advice on the quality, efficacy and safety of medicines, including Lariam, to the Licensing Authority.

Ms Corston: To ask the Secretary of State for Health if he will make a statement on the indicated side effects of the drug Lariam. [32283]

Mr. Malone: Warnings on the side effects of Lariam are included in the product information. This includes the data sheet provided to all doctors and pharmacists and the information leaflet for patients.

Magnetic Resonance Imaging Scans

Mr. Jim Cunningham: To ask the Secretary of State for Health (1) what is the average waiting time for an MRI scan in (a) north-east Warwickshire and (b) Walsgrave hospital, Coventry; [32254]

Mr. Horam: Information for England is not available centrally. Questions relating to Scotland, Wales and Northern Ireland are matters for my right hon. Friends the Secretaries of State for Scotland and for Wales and my right hon. and learned Friend the Secretary of State for Northern Ireland.

Civil Servants (Duties Abroad)

Mr. Donohoe: To ask the Secretary of State for Health how much his Department spent during the financial years 1994-95 and 1995-96 on sending civil servants accompanying Ministers from his Department on official duties abroad. [32416]

Mr. Horam: I refer the hon. Member to the reply I gave the hon. Member for Warrington, South (Mr. Hall) on 1 March, Official Report, columns 762-64. Within the overall cost of ministerial visits to other countries, it is not possible to identify separately the element attributable to civil servants accompanying Ministers.

13 Jun 1996 : Column: 239

General Medical Services (East London and City)

Ms Harman: To ask the Secretary of State for Health if he will make a statement on the general medical services budget and proposed budget in the East London and City health authority. [32561]

Mr. Malone: I refer the hon. Member to the reply I gave the right hon. Member for Derby, South (Mrs. Beckett) on 21 April 1995, Official Report, column 312.

Oral Contraceptives

Mr. Simon Hughes: To ask the Secretary of State for Health, pursuant to his answer to the hon. Member for Gordon (Mr. Bruce) of 19 December 1995, Official Report, column 1153, what factors prevented commencement of the despatch of letters relating to desogestrel and gestodene before 16.30 on 18 October 1995. [32723]

Mr. Malone: My right hon. Friend the Secretary of State for Health made an oral statement to the House on 23 October 1995, columns 701-02 which described the urgent arrangements put in place to communicate the Committee on Safety of Medicines' advice to health professionals. In addition, I refer the hon. Member to the reply I gave him on 5 June, Official Report, column 448.

Medicines Commission

Mr. Simon Hughes: To ask the Secretary of State for Health if he will list the members of the Medicines Commission as at 1 January indicating for each member his or her principal professional appointment, the date of first appointment to the commission, the scheduled termination of the period of membership and which of the criteria laid out in section 2(3) of the Medicines Act 1968 is relevant to the appointment of each member. [32722]

Mr. Malone: Members of the Medicines Commission are appointed for their knowledge and expertise which encompass the activities set out in section 2(3) of the Medicines Act 1968. The members of the Medicines Commission, as at 1 January 1996, are listed in the table, indicating for each member his or her principal professional appointment, the date of first appointment and the scheduled termination date of the current period of membership.

Date of first appointment End of current membership

Dr. Christine McCartney BSc PhD FRCPath Assistant Director of the Public Health Laboratory Service, London 1 January 1996 31 December 1999

Dr. Agnes McKnight MD MB Bch FRCGP Regional Adviser in General Practice, Belfast 1 January 1996 31 December 1999

Mr. David Miller BVMS (Glas) MRCVS Advisor on Medicines to British Veterinary Association 1 January 1996 31 December 1999

Professor J. Michael Newton BPharm PhD DSc FRPharmS Head of Department of Pharmaceutics, The School of Pharmacy, University of London 1 January 1996 31 December 1999

Professor Stuart Pocock BA MSc PhD Professor of Medical Statistics, London School of Hygiene and Tropical Medicine 1 January 1996 31 December 1999

Dr Andrew Renwick BSc PHD DSc Reader in Clinical Pharmacology, University of Southampton 1 January 1992 31 December 1999

Mrs Jane Short BPharm MRPharmS Associate Director, Procter and Gamble 1 January 1994 31 December 1997

Dr. David Williams BSc PhD CChem FRSC Director, Anitox Ltd. 1 January 1985 31 December 1999

Cowan Wilson Esq OBE BVMS FRCVS General Veterinary Practitioner, Fife 1 January 1985 31 December 1999

Professor David Lawson CBE MD FRCPEdin FRCPGlasg FFPM (Chairman) Consultant Physician, Glasgow Royal Infirmary, Honorary Professor of Medicine, University of Glasgow and Visiting Professor, University of Strathclyde 1 January 1994 31 December 1997

Professor Stuart Campbell MB ChB FRCOG DObst Professor of Obstetrics and Gynaecology and Head of Department, Kings College School of Medicine and Dentistry, London 1 January 1994 31 December 1997

Professor Stanley Davis BPharm PhD DSc FRSChem FRPharmS Lord Trent Professor of Pharmacy and Head of Department, Nottingham University 1 January 1994 31 December 1997

Professor Anthony Dayan MD FRCP FRCPath FFOM FFPM FTBioL Professor of Toxicology, St. Bartholomew's Hospital, London 1 January 1986 31 December 1997

Professor Edzard Ernst MD PhD Director of the Centre for Complementary Health Studies, University of Exeter 1 January 1994 31 December 1999

Professor Ronald Jones MVSc Dr Med Vet DVSc DVA DipECVA FIBiol FRCVS Professor of Veterinary Anaesthesia, University of Liverpool 1 January 1996 31 December 1999

Dr Parveen Kumar BSc MD FRCP FRCP(Edin) Senior Lecturer in Gastroenterology and Consultant Physician at St. Bartholomew's the Royal London and Homerton Hospitals 1 January 1994 31 December 1997

Miss Ann Lewis LLB FRPharmS MCPP Chief Pharmaceutical Officer, Countess of Chester Hospital 1 January 1994 31 December 1997

	Date of first appointment	End of current membership
Dr. Christine McCartney BSc PhD FRCPath Assistant Director of the Public Health Laboratory Service, London	1 January 1996	31 December 1999
Dr. Agnes McKnight MD MB Bch FRCGP Regional Adviser in General Practice, Belfast	1 January 1996	31 December 1999
Mr. David Miller BVMS (Glas) MRCVS Advisor on Medicines to British Veterinary Association	1 January 1996	31 December 1999
Professor J. Michael Newton BPharm PhD DSc FRPharmS Head of Department of Pharmaceutics, The School of Pharmacy, University of London	1 January 1996	31 December 1999
Professor Stuart Pocock BA MSc PhD Professor of Medical Statistics, London School of Hygiene and Tropical Medicine	1 January 1996	31 December 1999
Dr Andrew Renwick BSc PHD DSc Reader in Clinical Pharmacology, University of Southampton	1 January 1992	31 December 1999
Mrs Jane Short BPharm MRPharmS Associate Director, Procter and Gamble	1 January 1994	31 December 1997

Dr. David Williams BSc PhD CChem FRSC Director, Anitox Ltd.	1 January 1985	31 December 1999

Cowan Wilson Esq OBE BVMS FRCVS General Veterinary Practitioner, Fife	1 January 1985	31 December 1999

Professor David Lawson CBE MD FRCPEdin FRCPGlasg FFPM (Chairman) Consultant Physician, Glasgow Royal Infirmary, Honorary Professor of Medicine, University of Glasgow and Visiting Professor, University of Strathclyde	1 January 1994	31 December 1997

Professor Stuart Campbell MB ChB FRCOG DObst Professor of Obstetrics and Gynaecology and Head of Department, Kings College School of Medicine and Dentistry, London	1 January 1994	31 December 1997

Professor Stanley Davis BPharm PhD DSc FRSChem FRPharmS Lord Trent Professor of Pharmacy and Head of Department, Nottingham University	1 January 1994	31 December 1997

Professor Anthony Dayan MD FRCP FRCPath FFOM FFPM FTBioL Professor of Toxicology, St. Bartholomew's Hospital, London	1 January 1986	31 December 1997
Professor Edzard Ernst MD PhD Director of the Centre for Complementary Health Studies, University of Exeter	1 January 1994	31 December 1999

Professor Ronald Jones MVSc Dr Med Vet DVSc DVA DipECVA FIBiol FRCVS Professor of Veterinary Anaesthesia, University of Liverpool	1 January 1996	31 December 1999

Dr Parveen Kumar BSc MD FRCP FRCP(Edin) Senior Lecturer in Gastroenterology and Consultant Physician at St. Bartholomew's the Royal London and Homerton Hospitals	1 January 1994	31 December 1997
Miss Ann Lewis LLB FRPharmS MCPP Chief Pharmaceutical Officer, Countess of Chester Hospital	1 January 1994	31 December 1997

13 Jun 1996 : Column: 241

Cancelled Operations

Ms Harman: To ask the Secretary of State for Health how many operations were cancelled in the NHS (a) last year and (b) in each of the previous 10 years. [32806]

Mr. Horam: Information is available for the last two years only. Tables will be placed in the Library.

Committee on Safety of Medicines

Mr. Simon Hughes: To ask the Secretary of State for Health what is the statutory basis for the appointment of members for the day of the Committee on Safety of Medicines. [32724]

Mr. Malone: All members of the Committee on Safety of Medicines are appointed under section 4(5) of the Medicines Act 1968. In the case of members for the day, the terms in their letters of appointment limit membership to a particular meeting of the committee. The statutory basis for such terms is regulation 4 of the Medicines Commission and Committees Regulation 1970 (S.I. No. 746).

Next Section

Index

Home Page